SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Neuland Laboratories informs about newspaper advertisement

17 Jun 2025 Evaluate

Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015, Neuland Laboratories has informed that it enclosed copies of newspaper advertisement regarding intimation of 41st Annual General Meeting of the Company to be held through Video Conferencing (VC) facility/Other Audio Visual Means (OAVM), record date and other related information, as published in Financial Express and Andhra Prabha on June 17, 2025.

The above information is a part of company’s filings submitted to BSE.

Neuland Laboratories Share Price

14815.00 -116.45 (-0.78%)
22-Apr-2026 09:57 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.00
Dr. Reddys Lab 1215.55
Cipla 1226.00
Zydus Lifesciences 928.65
Lupin 2298.85
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×